Advances in the therapeutic algorithm for myasthenia gravis

Nat Rev Neurol. 2023 Jul;19(7):393-394. doi: 10.1038/s41582-023-00825-y.

Author

Marinos C Dalakas^{1

2}

Affiliations

¹ Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. marinos.dalakas@jefferson.edu.
² Neuroimmunology Unit, National and Kapodistrian University, University of Athens Medical School, Athens, Greece. marinos.dalakas@jefferson.edu.

PMID: 37253854
DOI: 10.1038/s41582-023-00825-y

No abstract available

Publication types

Comment

MeSH terms

Humans
Immunosuppressive Agents / therapeutic use
Myasthenia Gravis* / drug therapy
Myasthenia Gravis* / therapy

Substances

Immunosuppressive Agents